ArticleBlood2023

Activation of the PP2A-B56α heterocomplex synergizes with venetoclax therapies in AML through BCL2 and MCL1 modulation.

Irene Peris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.